Monsanto ally Novozymes sees opportunity, risk in Bayer merger

LONDON (Reuters) - Novozymes , already grappling with the consequences of low oil and crop prices, is watching anxiously to see what Bayer's purchase of Monsanto will mean for the Danish group's ties with its key agricultural partner.

Monsanto ally Novozymes sees opportunity, risk in Bayer merger
Read More


Bagikan Berita Ini